Publication Cover
Archives of Andrology
Journal of Reproductive Systems
Volume 29, 1992 - Issue 3
81
Views
1
CrossRef citations to date
0
Altmetric
Original Article

Acrosome Reaction Changes the Pattern of Cyclic Nucleotide Phosphodiesterases in Human Sperm

&
Pages 239-245 | Published online: 09 Jul 2009
 

Abstract

Three categories of cyclic nucleotide phosphodiesterases (cNPDE) are distinguished at present: type 1 with high affinity to cyclic GMP; type 2 with low affinity to cyclic AMP and to cyclic GMP; and type 3 with high affinity to cyclic AMP. For the evaluation of normal values in human spermatozoa 50 semen samples with normal classical semen parameters were investigated. The activities (means ± SD) of the cNPDE types (10−11 mol/10 min × 108 spermatozoa) of washed human spermatozoa amounted to 47 ± 22 (type 1), 3350 ± 1537 (type 2), and 70 + 38 (type 3). A significant inhibition of type 3 by cyclic GMP could not be detected. One milligram protein of the spermatozoa hydrolyzed about 20-fold the amount of cyclic nucleotides compared with 1 mg protein of the seminal plasma. Furthermore, the cNPDE of the spermatozoa and of the seminal plasma differed in the influence of type 3 by cyclic GMP and in the pattern of activities. The acrosome reaction (AR) induced by the cold shock method led to an activation of type 2 and 3 unlike the initiation of the AR by the digitonin method. The latter did not cause significant differences of the cNPDE activities before and after the AR.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.